CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Very Low Risk0–0
- Low Risk1–1
- Moderate Risk2–2
- Moderate-High Risk3–3
The CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk calculator is designed for bedside calculating the risk of stroke in patients with non-valvular atrial fibrillation, aiding in the decision regarding oral anticoagulation in clinical practice. The resulting score directly guides clinician decision-making regarding initiating guideline-directed medical.
Clinical Guidelines & Evidence
Calculates the risk of stroke in patients with non-valvular atrial fibrillation, aiding in the decision regarding oral anticoagulation
Clinical Indication
The CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk is indicated for bedside clinical practice to support Calculates the risk of stroke in patients with non-valvular atrial fibrillation, aiding in the decision regarding oral anticoagulation. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.
CHA₂DS₂-VASc = C + H + A₂ + D + S₂ + V + A + Sc
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient's age in years(years) |
| sex | string | Yes | Patient's biological sex |
| congestive_heart_failure | boolean | Yes | History of congestive heart failure or left ventricular dysfunction (LVEF ≤40%) |
| hypertension | boolean | Yes | History of arterial hypertension |
| stroke_tia_thromboembolism | boolean | Yes | Previous history of stroke, TIA (transient ischemic attack) or thromboembolism |
| vascular_disease | boolean | Yes | Vascular disease (previous myocardial infarction, peripheral artery disease or aortic plaque) |
| diabetes | boolean | Yes | History of diabetes mellitus |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Very Low Risk | Annual stroke risk: 0.3% |
| 1–1 | Low Risk | Annual stroke risk: 0.9% |
| 2–2 | Moderate Risk | Annual stroke risk: 2.9% |
| 3–3 | Moderate-High Risk | Annual stroke risk: 4.6% |
| 4–4 | High Risk | Annual stroke risk: 6.7% |
| 5–5 | High Risk | Annual stroke risk: 10.0% |
| 6–6 | Very High Risk | Annual stroke risk: 13.6% |
| 7–9 | Extreme Risk | Annual stroke risk: >15% |
Evidence-Based References (EBM)
- Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263-72.
- January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2019;140(2):e125-e151.
- Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. Eur Heart J. 2021;42(5):373-498.